Regardless of legislative reform in Canada and accompanying
market excitement in both the US and EU, cannabis companies are
failing to maintain momentum, while retail and wholesale
investors are either too cautious or simply blocked from
participating in the burgeoning market.
Global regulatory divergence has rendered cannabis companies
in Canada – many of which had expected rapid global
expansion – unable to grow, and left grappling with
relatively small domestic markets.
"When cannabis legalisation was first on the agenda in
Canada, we had borderline hysteria about the amount of money
people thought they could make," said Nick Pateras, Europe
managing director at Materia Ventures, a Canadian company
specialising in CBD and medical cannabis. "However, three to
five years of excitement shifted into broader concerns about
how quickly the market was growing, regulatory twists, and how
quickly profits would surface."
Pateras explained that even certain states within Canada,
such as Ontario, have not...